查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1610019

乳癌近距離放射治療市場規模、佔有率、趨勢分析報告：按技術、按產品、按地區、細分市場預測，2025-2030 年

Breast Cancer Brachytherapy Market Size, Share & Trends Analysis Report By Technology (HDR, LDR), By Product (Applicators And Afterloaders, Electronic Brachytherapy), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

乳癌近距離治療市場成長與趨勢

Grand View Research, Inc.最新報告顯示，預計2030年全球乳癌近距離治療市場規模將達13億美元，2025年至2030年複合年成長率為6.9%。乳癌盛行率的增加預計將加速市場成長。例如，根據 Breastcancer.org 的報告，截至 2020 年 1 月，美國有超過 350 萬名女性罹患乳癌。

此外，學術醫療中心、腫瘤中心和醫院擴大採用近距離放射治療，預計也將促進市場成長。例如，2018年10月，Navicent Health選擇了iCAD, Inc.開發的Xoft Axxent電子近距離放射治療（eBx）系統來治療喬治亞的乳癌。此外，2018 年 10 月，紐約州立大學上州醫科大學選擇 Xoft Axxent 電子近距離放射治療 (eBx) 系統來治療早期乳癌。

此外，開發中國家的政府醫院正在實施先進的系統，為病患提供更優質的照護。例如，2018 年 8 月，Eckert 和 Ziegler BEBIG 在尼泊爾 BP Koirala Memorial 癌症醫院交付並安裝了 SagiNova HDR後荷機。 SagiNova 適用於間質性乳房植入。因此，醫院使用此類近距離放射治療系統預計將推動市場成長。

市場參與企業參與合作研究和夥伴關係等策略性舉措預計將在未來幾年推動需求。例如，2018 年 7 月，RaySearch 與 Eckert 和 Ziegler BEBIG 合作，將 SagiNova 與 RayCare 腫瘤資訊系統和 RayStation 治療計劃系統整合，以改善近距離放射治療期間的治療效果。

據估計，醫療中心 HDR 單位機構資助舉措的增加將推動市場發展。例如，2019 年 4 月，OSJ 慈善信託基金與義大利加拿大人全國聯合會合作，將 SagiNova 引入 Santo Spirito 醫院，作為體外放射治療的替代方案，以實現有針對性的治療和更快的治療時間。

針對腫瘤科醫生、外科醫生和醫院的有利報銷政策預計將推動市場成長。例如，根據醫療保險和醫療補助服務中心 (CMS) 發布的編碼，5 天治療期的 HDR 近距離放射治療的醫療保險報銷為 11,000 美元。

乳癌近距離放射治療市場報告亮點

  • HDR 近距離放射治療預計將在 2024 年佔據市場主導地位，並成為預測期內成長最快的技術領域。
  • 快速放射治療、短時間內精準的腫瘤特異性劑量治療等因素預計將推動此領域的發展。
  • 由於主要參與企業的存在以及腫瘤中心和醫院擴大採用該治療方法，北美將在 2024 年佔據市場主導地位。
  • 由於投資者和公司在該地區擴大業務的需求和成長機會未被滿足，預計亞太地區的市場在預測期內將快速成長。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章乳癌近距離放射治療市場變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 營商環境分析
    • 產業分析-波特五力分析
    • PESTLE分析

第4章乳癌近距離治療市場：技術業務分析

  • 2024年及2030年技術市場佔有率
  • 技術細分儀表板
  • 2018-2030 年按技術分類的市場規模、預測與趨勢分析
  • HDR（高劑量率）
  • LDR（低劑量率）

第5章乳癌近距離治療市場：產品業務分析

  • 2024年及2030年產品市場佔有率
  • 產品細分儀表板
  • 2018-2030 年按產品分類的市場規模、預測與趨勢分析
  • 施用器和後荷機
  • 電子近距離放射治療
  • 其他

第6章乳癌近距離治療市場：技術、產品、區域、估計和趨勢分析

  • 2024 年及 2030 年按地區分類的市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
    • 按國家/地區分類，2018-2030
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 按國家/地區分類，2018-2030
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 丹麥
    • 瑞典
  • 亞太地區
    • 按國家/地區分類，2018-2030
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 按國家/地區分類，2018-2030
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 按國家/地區分類，2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 參與者概覽
  • 公司市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介/上市公司
    • Eckert &Ziegler BEBIG
    • Elekta
    • Varian Medical Systems, Inc.
    • Hologic, Inc.
    • Merit Medical Systems
    • BD
Product Code: GVR-4-68038-953-1

Breast Cancer Brachytherapy Market Growth & Trends:

The global breast cancer brachytherapy market size is estimated to reach USD 1.3 billion by 2030, expanding at a CAGR of 6.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of breast cancer is expected to accelerate market growth. For instance, the Breastcancer.org reported that as of January 2020, there were more than 3.5 million women suffering from breast cancer in the U.S.

In addition, the rising adoption of brachytherapy by academic medical centers, oncology centers, and hospitals is expected to boost the market growth. For instance, in October 2018, Navicent Health adopted the Xoft Axxent Electronic Brachytherapy (eBx) System developed by iCAD, Inc. for the treatment of breast cancer in Georgia. Furthermore, in October 2018, SUNY Upstate Medical University also adopted the Xoft Axxent Electronic Brachytherapy (eBx) System to provide treatment for early-stage breast cancer.

Moreover, government hospitals in developing countries are installing advanced systems to provide better quality treatment for their patients. For instance, in August 2018, Eckert and Ziegler BEBIG delivered and installed SagiNova HDR afterloader at BP Koirala Memorial Cancer Hospital of Nepal. SagiNova is suitable for interstitial breast implants. Hence, the use of such brachytherapy systems by hospitals is expected to fuel market growth.

Market players entering into strategic initiatives such as collaborations and partnerships are anticipated to propel the demand over the next few years. For instance, in July 2018, RaySearch partnered with Eckert and Ziegler BEBIG to integrate SagiNova with the RayCare oncology information system and RayStation treatment planning system to improve treatment outcomes during brachytherapy.

An increase in funding initiatives for HDR units in medical centers by organizations is estimated to drive the market. For instance, in April 2019, OSJ Charities Trust Fund collaborated with the National Federation of Italian Canadians to donate SagiNova for Santo Spirito Hospital as an alternative to external beam radiation therapy for a targeted approach and shorter treatment time.

Favorable reimbursement policies for oncologists, surgeons, and hospitals are expected to fuel market growth. For instance, HDR brachytherapy offers USD 11,000 as Medicare reimbursement for five days treatment period according to the coding issued by Centers for Medicare and Medicaid Services (CMS).

Breast Cancer Brachytherapy Market Report Highlights:

  • HDR brachytherapy dominated the market in 2024 and is also projected to be the fastest-growing technology segment over the forecast period
  • Factors such as rapid delivery of radiation, accuracy, and precise tumor-specific dose delivery in a shorter period of time are expected to drive the segment
  • North America has dominated the market in 2024 owing to the presence of key players and increasing adoption of the therapy by oncology centers and hospitals
  • In Asia Pacific, the market is estimated to grow fast over the forecast period due to high unmet needs and growth opportunities for investors and companies to expand their presence in the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Product
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Breast Cancer Brachytherapy Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Breast Cancer Brachytherapy Market: Technology Business Analysis

  • 4.1. Technology Market Share, 2024 & 2030
  • 4.2. Technology Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 4.4. High Dose Rate (HDR)
    • 4.4.1. High Dose Rate (HDR) Market, 2018 - 2030 (USD Million)
  • 4.5. Low Dose Rate (LDR)
    • 4.5.1. Low Dose Rate (LDR) Market, 2018 - 2030 (USD Million)

Chapter 5. Breast Cancer Brachytherapy Market: Product Business Analysis

  • 5.1. Product Market Share, 2024 & 2030
  • 5.2. Product Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 5.4. Applicators and Afterloaders
    • 5.4.1. Applicators and Afterloaders Market, 2018 - 2030 (USD Million)
  • 5.5. Electronic Brachytherapy
    • 5.5.1. Electronic Brachytherapy Market, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Breast Cancer Brachytherapy Market: Regional Estimates & Trend Analysis by Technology and Product

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Breast Cancer Brachytherapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Breast Cancer Brachytherapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Norway
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Norway Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Denmark Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Sweden Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Breast Cancer Brachytherapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Breast Cancer Brachytherapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Breast Cancer Brachytherapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Eckert & Ziegler BEBIG
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Elekta
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Varian Medical Systems, Inc.
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Hologic, Inc.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Merit Medical Systems
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. BD
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global breast cancer brachytherapy market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 5 Global breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 6 North America breast cancer brachytherapy market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 8 North America breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 10 U.S. breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 11 Canada breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 12 Canada breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 13 Mexico breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 14 Mexico breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 15 Europe breast cancer brachytherapy market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 17 Europe breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 18 UK breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 19 UK breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 20 Germany breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 21 Germany breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 22 France breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 23 France breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 24 Italy breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 25 Italy breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 26 Spain breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Spain breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 28 Norway breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 29 Norway breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 30 Denmark breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 31 Denmark breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 32 Sweden breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Sweden breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific breast cancer brachytherapy market, by country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 37 Japan breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 38 Japan breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 39 China breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 40 China breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 41 India breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 42 India breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 43 Australia breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 44 Australia breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 45 South Korea breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 46 South Korea breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 47 Thailand breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 48 Thailand breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 49 Latin America breast cancer brachytherapy market, by country, 2018 - 2030 (USD Million)
  • Table 50 Latin America breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 51 Latin America breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 52 Brazil breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 53 Brazil breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 54 Argentina breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 55 Argentina breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Breast cancer brachytherapy market, by country, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 59 South Africa breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 60 South Africa breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 63 UAE breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 64 UAE breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 65 Kuwait breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 66 Kuwait breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Breast cancer brachytherapy market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Technology and product outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Breast cancer brachytherapy market dynamics
  • Fig. 12 Breast cancer brachytherapy market: Porter's five forces analysis
  • Fig. 13 Breast cancer brachytherapy market: PESTLE analysis
  • Fig. 14 Breast cancer brachytherapy market: Technology segment dashboard
  • Fig. 15 Breast cancer brachytherapy market: Technology market share analysis, 2024 & 2030
  • Fig. 16 High dose rate (HDR) market, 2018 - 2030 (USD Million)
  • Fig. 17 Low dose rate (LDR) market, 2018 - 2030 (USD Million)
  • Fig. 18 Breast cancer brachytherapy market: Product segment dashboard
  • Fig. 19 Breast cancer brachytherapy market: Product market share analysis, 2024 & 2030
  • Fig. 20 Applicators and afterloaders market, 2018 - 2030 (USD Million)
  • Fig. 21 Electronic brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 22 Others market, 2018 - 2030 (USD Million)
  • Fig. 23 Breast cancer brachytherapy market revenue, by region
  • Fig. 24 Regional marketplace: Key takeaways
  • Fig. 25 Regional marketplace: Key takeaways
  • Fig. 26 North America breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. country dynamics
  • Fig. 28 U.S. breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 29 Canada country dynamics
  • Fig. 30 Canada breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 31 Mexico country dynamics
  • Fig. 32 Mexico breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 33 Europe breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 34 UK country dynamics
  • Fig. 35 UK breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 36 Germany country dynamics
  • Fig. 37 Germany breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 38 France country dynamics
  • Fig. 39 France breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 40 Italy country dynamics
  • Fig. 41 Italy breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 42 Spain country dynamics
  • Fig. 43 Spain breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 44 Norway country dynamics
  • Fig. 45 Norway breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 46 Sweden country dynamics
  • Fig. 47 Sweden breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 48 Denmark country dynamics
  • Fig. 49 Denmark breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 50 Asia Pacific breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 51 Japan country dynamics
  • Fig. 52 Japan breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 53 China country dynamics
  • Fig. 54 China breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 55 India country dynamics
  • Fig. 56 India breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 57 Australia country dynamics
  • Fig. 58 Australia breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 59 South Korea country dynamics
  • Fig. 60 South Korea breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 61 Thailand country dynamics
  • Fig. 62 Thailand breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 63 Latin America breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 64 Brazil country dynamics
  • Fig. 65 Brazil breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 66 Argentina country dynamics
  • Fig. 67 Argentina breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 68 MEA breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 69 South Africa country dynamics
  • Fig. 70 South Africa breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 71 Saudi Arabia country dynamics
  • Fig. 72 Saudi Arabia breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 73 UAE country dynamics
  • Fig. 74 UAE breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 75 Kuwait country dynamics
  • Fig. 76 Kuwait breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 77 Company categorization
  • Fig. 78 Company market position analysis
  • Fig. 79 Strategic framework